- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beam Therapeutics Inc (BEAM)
Beam Therapeutics Inc stock price live, this page displays NASDAQ BEAM stock exchange data. View the BEAM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beam Therapeutics Inc real time stock price chart below.
What Is the Beam Therapeutics Inc Stock Price Today?
The Beam Therapeutics Inc stock price today is 17.62.
What Is the Stock Symbol for Beam Therapeutics Inc?
The stock symbol for Beam Therapeutics Inc is ""BEAM.""
What Stock Exchange Does Beam Therapeutics Inc Trade On?
Beam Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Beam Therapeutics Inc a Good Stock to Buy?
Determining whether Beam Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BEAM quote. (ISIN: US07373V1052)
What Is the Beam Therapeutics Inc Stock Price Today?
The Beam Therapeutics Inc stock price today is 17.62.
What Is the Stock Symbol for Beam Therapeutics Inc?
The stock symbol for Beam Therapeutics Inc is ""BEAM.""
What Stock Exchange Does Beam Therapeutics Inc Trade On?
Beam Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Beam Therapeutics Inc a Good Stock to Buy?
Determining whether Beam Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BEAM quote. (ISIN: US07373V1052)
NASDAQ
Currency in USD
17.62
-0.24(-1.34%)
Real-time Data·
Fair Value
An estimate of a Beam's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.36
18.11
52 wk Range
13.53
35.25
BEAM Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BEAM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Beam's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.3618.11
52 wk Range
13.5335.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BEAM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Beam's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
43.80
Upside
+148.58%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Beam Therapeutics Inc Company Profile
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease; BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. It also intends to develop BEAM-103, an anti-CD117 monoclonal antibody, and BEAM-104, a cell therapy for development in sickle cell disease and beta-thalassemia; and BEAM-201 and other potential ex vivo CAR-T therapies. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.
Compare BEAM to Peers and Sector
Metrics to compare | BEAM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBEAMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.3x | −1.1x | −0.5x | |
PEG Ratio | 0.03 | −0.06 | 0.00 | |
Price/Book | 1.5x | 2.2x | 2.6x | |
Price / LTM Sales | 28.5x | 9.2x | 3.3x | |
Upside (Analyst Target) | 135.2% | 328.8% | 43.4% | |
Fair Value Upside | Unlock | 7.2% | 7.1% | Unlock |
Analyst Ratings
14 Buy
3 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 43.80
(+148.58% Upside)
Earnings
Latest Release
Aug 05, 2025
EPS / Forecast
-1.00 / -1.11
Revenue / Forecast
8.47M / 12.77M
People Also Watch
FAQ
What Stock Exchange Does Beam Trade On?
Beam is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Beam?
The stock symbol for Beam is "BEAM."
What Is the Beam Market Cap?
As of today, Beam market cap is 1.71B.
What Is Beam's Earnings Per Share (TTM)?
The Beam EPS (TTM) is -4.49.
When Is the Next Beam Earnings Date?
Beam will release its next earnings report on 09 Nov 2025.
From a Technical Analysis Perspective, Is BEAM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Beam Stock Split?
Beam has split 0 times.
How Many Employees Does Beam Have?
Beam has 393 employees.
What is the current trading status of Beam (BEAM)?
As of 08 Aug 2025, Beam (BEAM) is trading at a price of 17.62, with a previous close of 17.86. The stock has fluctuated within a day range of 17.36 to 18.11, while its 52-week range spans from 13.53 to 35.25.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.